Junichiro Yuda

A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression

Yoshikane Kikushige, Toshihiro Miyamoto, Junichiro Yuda et al. · Cell stem cell · 2015 · 273 citations · Full text

Hematological Malignancy, Cell Therapy, Mixed-phenotype Acute Leukemia +6

The critical role of CD4+ T cells in PD-1 blockade against MHC-II–expressing tumors such as classic Hodgkin lymphoma

Joji Nagasaki, Yosuke Togashi, Takeaki Sugawara et al. · Blood Advances · 2020 · 118 citations · Full text

Mhc Class, Pd-1 Blockade, Immunology +16

BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors

Kota Itahashi, Takuma Irie, Junichiro Yuda et al. · Science Immunology · 2022 · 94 citations

Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients

Junichiro Yuda, Christine Will, Darren C. Phillips et al. · Communications Medicine · 2023 · 52 citations · Full text

Phase 1 Results: First-in-Human Phase 1/2 Study of the Menin-MLL Inhibitor Enzomenib (DSP-5336) in Patients with Relapsed or Refractory Acute Leukemia

Joshua F. Zeidner, Junichiro Yuda, Justin M. Watts et al. · Blood · 2024 · 31 citations